Ptc Therapeutics (PTCT) Current Assets (2012 - 2026)

Ptc Therapeutics' Current Assets history runs 15 years deep, the most recent figure standing at $2.6 billion for Q2 2026.

• In Q2 2026, Current Assets rose 15.16% year-over-year to $2.6 billion; the TTM figure through Jun 2026 stood at $2.6 billion (up 15.16% YoY), while the FY2025 annual figure was $2.3 billion, up 66.52% from the prior year.
• Current Assets for Q2 2026 stood at $2.6 billion, up from $2.3 billion in the prior quarter.
• The five-year high for Current Assets was $2.6 billion in Q2 2026, with the low at $517.3 million in Q3 2022.
• The 5-year median for Current Assets is $1.3 billion (2023), against an average of $1.4 billion.
• The sharpest annual moves came in 2022 and 2024: Current Assets plunged 48.84% in 2022, then soared 137.17% in 2024.
• Ptc Therapeutics' Current Assets stood at $693.8 million in 2022, then soared by 75.65% to $1.2 billion in 2023, then advanced by 12.05% to $1.4 billion in 2024, then jumped by 66.52% to $2.3 billion in 2025, then climbed by 15.1% to $2.6 billion in 2026.
• Business Quant data shows PTCT's Current Assets at $2.6 billion in Q2 2026, $2.3 billion in Q1 2026, and $2.3 billion in Q4 2025.